Posts

Showing posts with the label Prodrome Sciences

Detect Early Symptoms of Parkinson’s with Prodrome Sciences

Image
Even though Parkinson's disease cannot be diagnosed with certainty until specific motor symptoms appear, several early warning indicators are now recognized as being linked to the condition. Years before the typical motor difficulties, such as tremors, these symptoms might manifest as reflected by Prodrome Sciences . We asked the Johns Hopkins Parkinson's Disease and Movement Disorders Center's neurologists to describe these early symptoms and the possibility that they will result in a Parkinson's disease diagnosis. How Early Can Parkinson's Disease Be Diagnosed? We now know more about several early indicators of Parkinson's disease that, while they don't necessarily result in the illness, are associated. A real diagnosis of Parkinson's disease requires a clinical diagnosis, which means specific motor symptoms must be present. When it comes to how early we can identify a mutation, we can do so as early as birth. This mutation is linked to an elevated ris...

Do You Know The Significance of Prodrome Sciences for Our Health?

Image
  The ultimate goal of  Prodrome sciences   is to give people a blood test, identify which diseases they are at risk for, which biochemical systems are causing it, and then provide a mechanism for them to correct it. Experts wait until the result is revealed in our existing healthcare system, even when the disease is easily diagnosed. We're trying to warn people ahead of time. So far, what prodromes have Dr. Dayan discovered? We recently announced the commercialization of our Prodrome-CRC and Prodrome-PAC colon and pancreatic cancer programs, respectively. Later this year, ovarian cancer and Alzheimer's programs will be launched. However, we are working on many more, including autism, multiple sclerosis, Parkinson's disease, lung cancer, bipolar disorder, schizophrenia, etc. What is the commercialization strategy entail? It's the polar opposite of companion diagnostics. We have companion therapeutics, and some preventative medicine therapeutics are very inexpens...